# Triptorelin and Radiation Therapy in Treating Patients Who Have Undergone Surgery for Intermediate-Risk Stage III or Stage IV Prostate Cancer

> **NCT00667069** · PHASE3 · COMPLETED · sponsor: **UNICANCER** · enrollment: 424 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **DRUG:** triptorelin
- **PROCEDURE:** adjuvant therapy
- **RADIATION:** 3-dimensional conformal radiation therapy

## Key facts

- **NCT ID:** NCT00667069
- **Lead sponsor:** UNICANCER
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-04-07
- **Primary completion:** 2020-04
- **Final completion:** 2022-05-24
- **Target enrollment:** 424 (ACTUAL)
- **Last updated:** 2025-06-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00667069

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00667069, "Triptorelin and Radiation Therapy in Treating Patients Who Have Undergone Surgery for Intermediate-Risk Stage III or Stage IV Prostate Cancer". Retrieved via AI Analytics 2026-07-28 from https://api.ai-analytics.org/clinical/NCT00667069. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*